Search results for: 'preferred desalination for clinical trials'
- Related search terms
- forces managed security services market study
- clinical communications market research
- clinical environment market size ® invest 2025
- clinical environment market size ® invest 2030
- clinical environment market size ® invest 2020
-
11 Dec 2023  |  Asia Pacific  |  Frost Radar
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Aug 2020  |  Global  |  Market Research
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new t...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 Jul 2024  |  Global  |  Frost Radar
Frost Radar™: Clinical-Grade Wearables, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Oct 2024  |  Global  |  Market Research
Clinical Chemistry and Immunoassay Industry, Global, 2023?2028
Integrated and Scalable Core Lab Solutions Driving Transformational Growth
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...
$4,950.00
Special Price $4,207.50 save 15 %
-
16 Jan 2024  |  Global  |  Market Research
Top 5 Growth Opportunities for Clinical Diagnostics, 2024
Enabling Precision Health Journey Through Omics, Digital Diagnostics Services, and Smart Screening Solutions
Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Sep 2023  |  North America  |  Market Research
Growth Opportunities for Clinical Laboratory Services in Asia-Pacific
Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential
Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding f...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Apr 2025  |  North America  |  Frost Radar
Frost Radar™: Clinical Documentation Integrity in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, ...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 Mar 2026  |  Global  |  Market Research
Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
Next-Gen AI-Integrated Biomarkers and Smart Automation are Advancing Precision and Early Detection in Molecular and Point-of-Care Diagnostics
The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...
$4,950.00 -
12 Dec 2024  |  Global  |  Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...
$2,450.00
Special Price $2,082.50 save 15 %